Exelixis director sells 60,000 shares in open market

EXELIXIS, INC. director George Poste reported an open-market sale of 60,000 shares of common stock on May 7, 2026 at a weighted average price of $45.71 per share.

Rhea-AI Filing Summary

EXELIXIS, INC. director George Poste reported an open-market sale of 60,000 shares of common stock on May 7, 2026 at a weighted average price of $45.71 per share. The transactions were executed in multiple trades between $45.65 and $45.85 per share.

Following the sale, Poste directly holds 118,832 shares of Exelixis common stock, which includes 9,812 shares that will be issued upon vesting of restricted stock units (RSUs). Each RSU represents the economic equivalent of one share of common stock.

Insider Trade Summary

Net Seller: 60,000 shares

Net Sell 1 txn

Insider POSTE GEORGE

Role Director

Sold 60,000 shs ($2.74M)

Type	Security	Shares	Price	Value
Sale	Common Stock	60,000	$45.71	$2.74M

Holdings After Transaction: Common Stock — 118,832 shares (Direct)

Footnotes (2)

1. F1. Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $45.65 to $45.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
2. F2. Includes 9,812 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Key Figures

Shares sold: 60,000 shares Weighted average sale price: $45.71 per share Post-transaction holdings: 118,832 shares +2 more

5 metrics

Shares sold 60,000 shares Open-market sale on May 7, 2026

Weighted average sale price $45.71 per share Common stock sale on May 7, 2026

Post-transaction holdings 118,832 shares Common stock directly held after sale

RSUs included in holdings 9,812 shares Shares to be issued upon RSU vesting

Trade price range $45.65–$45.85 per share Price range of multiple sale transactions

Key Terms

open-market sale, restricted stock units, weighted average sales price, Form 4

4 terms

open-market sale financial

"reported an open-market sale of 60,000 shares of common stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

restricted stock units financial

"Includes 9,812 shares of Common Stock that will be issued ... upon vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average sales price financial

"Represents the weighted average sales price. The shares ... were sold in multiple transactions"

Form 4 regulatory

"within the ranges set forth in footnote 1 to this Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EXEL director George Poste report on this Form 4?

George Poste reported an open-market sale of 60,000 shares of Exelixis common stock. The sale was executed on May 7, 2026 at a weighted average price of $45.71 per share, across multiple trades between $45.65 and $45.85.

At what prices did George Poste sell EXEL (Exelixis) shares?

The reported 60,000 Exelixis shares were sold at a weighted average price of $45.71. According to the filing, the individual trades occurred in a price range from $45.65 to $45.85 per share during the May 7, 2026 transactions.

How many EXEL shares does George Poste hold after this Form 4 sale?

After the reported sale, George Poste holds 118,832 Exelixis common shares directly. This total includes 9,812 shares that will be issued upon vesting of restricted stock units, which are equity awards economically equivalent to common shares.

Does George Poste’s EXEL Form 4 include restricted stock units (RSUs)?

Yes. The filing states his post-transaction holdings of 118,832 Exelixis shares include 9,812 shares tied to RSUs. Each RSU is the economic equivalent of one share of common stock and will convert into shares upon vesting, increasing his deliverable holdings.

What does “weighted average sales price” mean in George Poste’s EXEL filing?

Weighted average sales price is the average price of all shares sold, weighted by the number of shares at each price. Poste’s 60,000 Exelixis shares were sold in multiple trades between $45.65 and $45.85, resulting in a weighted average of $45.71 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 07:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POSTE GEORGE

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		S		60,000	D	$45.71(1)	118,832(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $45.65 to $45.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

2. Includes 9,812 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)